Australia, Sept. 18 -- Merck KGaA, owns the trademark (2665805) for 'TRUVERNA' till April 30, 2036.
Status: protected:
Registered/protected
Class: 42 [Biological research, clinical research and medical research; scientific research; pharmaceutical research and development; preparation of reports relating to scientific research; research and development services in the field of antibodies; research and testing services in the fields of bacteriology and virology; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; consultancy relating to pharmaceutical research and development; preparation of scientific reports; conducting of scientific studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; pharmaceutical product evaluation; genetic testing for scientific research purposes; research and development services in the field of gene therapy; testing services in the field of antibodies; testing services for vaccines and medicines; research and development in the field of cell therapies; testing services for gene or cell therapies.]
Type of Mark: Word
Date of Acceptance: July 10
Registration Advertised: Sept. 17
For further details contact Merck KGaA.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2665805.
Disclaimer: Curated by HT Syndication.
